2nd Edition: New Perspectives of Ocular Oncology
Deadline for manuscript submissions: closed (5 December 2023) | Viewed by 175
Interests: ocular oncology; orbital tumors; uveal melanoma; ocular metastasis; retinoblastoma; molecular biomarkers of solid tumors; imaging of ocular tumors; radiation side effects; rare tumors
Special Issues, Collections and Topics in MDPI journals
This collection is the second edition of the previous Special Issue "New Perspectives of Ocular Oncology": https://www.mdpi.com/journal/cancers/special_issues/NPOC.
Ocular oncology is a subspeciality of ophthalmology, dedicated to the research, diagnosis, and treatment of neoplastic lesions affecting the eye and its adnexa, including the orbit. In recent years, progress in the identification of new intraocular biomarkers of eye neoplasia, new diagnostic imaging technologies, and some new insights into treatment modalities have contributed to the advancement of this subspecialty. The local treatment of benign intraocular tumors and metastatic intraocular disease is also a challenging topic. Local tumor irradiation is the most common treatment of uveal melanoma, the most common primary intraocular tumor in adults. The prevention and treatment of radiation chorioretinopathy deserve special attention, mostly because personalized therapy may contribute to vision salvage. Intraocular tumors in pediatric age have also received special attention from the genetic and pathophysiologic approach. Therefore, ocular oncology not only needs attention from ophthalmologists, but also from all medical specialties involved in the diagnosis and treatment of ocular and orbital tumors. This Special Issue is devoted to reporting on new aspects of this subspeciality, from any perspective.
Prof. Dr. Edoardo Midena
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- ocular oncology
- orbital tumors
- uveal melanoma
- diagnosis and treatment